PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
8.05
-0.08 (-0.98%)
At close: May 5, 2026, 4:00 PM EDT
8.05
0.00 (0.00%)
After-hours: May 5, 2026, 4:10 PM EDT
PAVmed Revenue
In the year 2025, PAVmed had annual revenue of $71.00K, down -97.63%. PAVmed had revenue of $52.00K in the quarter ending December 31, 2025, with 420.00% growth.
Revenue (ttm)
$71.00K
Revenue Growth
-97.63%
P/S Ratio
716.04
Revenue / Employee
$1,732
Employees
41
Market Cap
50.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.00K | -2.92M | -97.63% |
| Dec 31, 2024 | 3.00M | 543.00K | 22.15% |
| Dec 31, 2023 | 2.45M | 2.08M | 550.40% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Pulmonx | 88.55M |
| TELA Bio | 80.28M |
| Cytosorbents | 37.06M |
| electroCore | 32.03M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Elutia | 12.29M |
PAVM News
- 4 days ago - PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 - PRNewsWire
- 5 days ago - Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - PRNewsWire
- 11 days ago - Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - PRNewsWire
- 12 days ago - Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PRNewsWire
- 26 days ago - Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 weeks ago - PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - PRNewsWire
- 5 weeks ago - PAVmed Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire